ALiEM - Pharm Pearls

NOVEMBER 1, 2023

 Deferoxamine binds with ferric iron (Fe3+) to form ferrioxamine, a water-soluble compound excreted in the urine. As Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson’s disease. 22 Aug 2018. For iron toxicity, what are the indications for deferoxamine? PMID 10575418 Kaakkola S.

Clinical Pharmacology 161

Clinical Pharmacology Dosage Compounding 161

PharmD Live

MAY 30, 2024

The side effects can compound, resulting in a greater negative impact on a patient’s health than the individual effects of one medication alone. British Journal of Clinical Pharmacology, 67(6), 689–700. Retrieved from British Journal of Clinical Pharmacology Jyrkka, J., Watanabe et al., Korhonen, M.

Clinical Pharmacology 119

Clinical Pharmacology Hospitals Long-Term Care Facilities Dosage 119

Eye on FDA

AUGUST 4, 2021

When Breakthrough Therapy (BT) designation is granted, then the drug gets Fast Track status and receives more intensive guidance – which can begin as early as Phase I clinical trials. That said, BT would be a lagging indicator since it can be granted so early in the development process.

Clinical Pharmacology 122

Clinical Pharmacology Compounding Vaccines 122

RX Note

JANUARY 21, 2023

Regardless, this post is solely created as a collection of recommended reference.

Compounding 40

Compounding Community Pharmacies Clinical Pharmacology Dosage 40